Sales for the quarter ended at MNOK 67.4 (MNOK 74.6). Sales for 2016 ended at MNOK 268.1 (MNOK 251.4) which is a growth of 6.6 %. For the year, 20 MNOK of sales is lost related to the Medtronic products.
Currency neutral sales of own products decreased with 3 MNOK or 5.7 % due in part to a back order situation on TTFM flow probes. Currency neutral sales of own products increased with 9.5 % for the year. Operating profit (EBIT) for the quarter ended at MNOK 9.7 (MNOK 16.0). Operating profit for 2016 ended at MNOK 56.4 (MNOK 50.3). Continued strong development in the US where currency neutral growth in sales was 13.4 %. For 2016 currency neutral growth was 14.2 %.
Download the full report and presentation below: